arrow
S

Sophie Houard

Swiss Institute of Bioinformatics
H指数:16
被引数:966

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, Tolerability, and Immunogenicity of the InvaplexAR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
2025-01-080
OAAI
Phase 1b randomized, controlled, double-blinded, age de-escalation trial to evaluate the safety, reactogenicity and immunogenicity of BK-SE36/CpG malaria vaccine in Burkinabe healthy adults and children
2023-12-170
OA
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
2023-10-166
OAAI
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
2022-08-319
OAAI
The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes

佐剂gla-se促进人Tfh细胞扩增和公共tcr β 克隆型的出现

2019-06-0763
OAAI
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria

差异佐剂PAMVAC的首次人体,随机,双盲临床试验,预防妊娠相关疟疾的候选疫苗

2019-01-10109
OAAI
The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers
2018-06-2621
OA